Detalles de la búsqueda
1.
First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia.
Br J Haematol
; 204(5): 1913-1919, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420726
2.
Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
Br J Haematol
; 202(2): 356-368, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211753
3.
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
Br J Haematol
; 202(2): 256-266, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096915
4.
Benefits of plerixafor for mobilization of peripheral blood stem cells prior to autologous transplantation: a dual-center retrospective cohort study.
Cytotherapy
; 25(7): 773-781, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36914555
5.
Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation.
Cytotherapy
; 25(4): 407-414, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335019
6.
Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan.
Allergol Int
; 72(2): 297-305, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36470790
7.
[Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy].
Rinsho Ketsueki
; 64(5): 331-337, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-37271521
8.
LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells.
Blood
; 136(6): 684-697, 2020 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32325488
9.
Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era.
Cytotherapy
; 24(1): 49-58, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34654641
10.
Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
Cytotherapy
; 24(10): 1013-1025, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729020
11.
[Clinical experience of leukapheresis for CD19 CAR-T cell therapy].
Rinsho Ketsueki
; 62(3): 163-169, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-33828008
12.
Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis.
Platelets
; 30(8): 946-956, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30507320
13.
Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T-cell therapy.
Br J Haematol
; 200(1): e1-e3, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36220156
14.
Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis.
Haematologica
; 103(1): 163-171, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971908
15.
Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute.
Biol Blood Marrow Transplant
; 23(12): 2159-2165, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28822830
16.
Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model.
Transplant Cell Ther
; 30(4): 404-414, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281589
17.
Response to the Comment by Cirasino L and Semeraro S: "Need to direct immune thrombocytopenia therapy towards shared goals" Direct and indirect comparisons to determine the first choice for newly diagnosed primary immune thrombocytopenia in adults.
Haematologica
; 103(6): e269, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29866890
18.
Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 29(10): 634.e1-634.e7, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481244
19.
Risk analysis of fluctuating hypercalcemia after leukapheresis in cellular therapy.
Sci Rep
; 13(1): 14952, 2023 09 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37696885
20.
A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Commun Med (Lond)
; 3(1): 67, 2023 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37193882